GSE185200 GSE185202 L-13 Ali-BL 0 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE185200_GSE185202_L-13_Ali-BL_0_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE185200_GSE185202_L-13_Ali-BL_0_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE185200_GSE185202_L-13_Ali-BL_0_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE185200_GSE185202_L-13_Ali-BL_0_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 4

Gene

uncharacterized LOC100506271

Gene

small nucleolar RNA, H/ACA box 54

Gene

RNA, U11 small nuclear

Gene

small nucleolar RNA, H/ACA box 2C

Gene

small nucleolar RNA, H/ACA box 21

Gene

small nucleolar RNA, H/ACA box 68

Gene

small nucleolar RNA, H/ACA box 70

Gene

RN7SK pseudogene 187

Gene

small nucleolar RNA, H/ACA box 3A

  • Gene

    small nucleolar RNA host gene 4


  • Gene

    uncharacterized LOC100506271


  • Gene

    small nucleolar RNA, H/ACA box 54


  • Gene

    RNA, U11 small nuclear


  • Gene

    small nucleolar RNA, H/ACA box 2C


  • Gene

    small nucleolar RNA, H/ACA box 21


  • Gene

    small nucleolar RNA, H/ACA box 68


  • Gene

    small nucleolar RNA, H/ACA box 70


  • Gene

    RN7SK pseudogene 187


  • Gene

    small nucleolar RNA, H/ACA box 3A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.